Abstract
Studies on the association of the Pro12Ala and C1431T polymorphisms of PPARγ with diabetes and obesity have revealed extensive population-dependent variations. However, association of these polymorphisms with the metabolic syndrome and its individual components has not been well investigated in the Indian population. The Indian population harbours the maximum number of diabetics in the world who are thus more susceptible to metabolic disorders. We screened a South Indian population (N = 699) for a possible association of these polymorphisms with the metabolic syndrome (MS) and type 2 diabetes. We also investigated the correlation of these two single-nucleotide polymorphisms (SNPs) with plasma resistin levels. The C1431T SNP was associated with higher levels of plasma resistin (P = 0.017). Furthermore, C1431T was associated with resistin in different tertiles. Prevalence of the ‘Pro-C’ haplotype decreased with increasing tertiles of resistin (84.1% to 75.4%, P = 0.037). Plasma resistin levels were not found to be associated with MS and type 2 diabetes. These results point to a likely association of plasma resistin levels with PPARγ polymorphisms in the Indian population.
Similar content being viewed by others
Abbreviations
- BMI:
-
body mass index
- ELISA:
-
enzyme-linked immunosorbent assay
- EM:
-
expectation-maximization
- HDL:
-
high-density lipoprotein cholesterol
- IDF:
-
International Diabetes Federation
- IGT:
-
impaired glucose tolerance
- IL:
-
interleukin
- IRS:
-
insulin resistance syndrome
- LD:
-
linkage disequilibrium
- MS:
-
metabolic syndrome
- NCEP ATP-III:
-
National Cholesterol Education Program (NCEP) Adult Treatment Panel III
- PCR:
-
polymerase chain reaction
- PPAR:
-
peroxisome proliferator-activated receptor
- PPREs:
-
PPAR response elements
- RFLP:
-
restriction fragment length polymorphism
- SNP:
-
single-nucleotide polymorphism
- T2DM:
-
type 2 diabetes mellitus
- TNF:
-
tumour necrosis factor
References
Alberti K G and Zimmet P Z 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation; Diabet. Med. 15 539–553
Altshuler D, Hirschhorn J N, Klannemark M, Lindgren C M, Vohl M C, Nemesh J, Lane C R, Schaffner S F et al. 2000 The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes; Nat. Genet. 26 76–80
Barrett J C, Fry B, Maller J and Daly M J 2005 Haploview: analysis and visualization of LD and haplotype maps; Bioinformatics 21 263–265
Deeb S S, Fajas L, Nemoto M, Pihlajamaki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W et al. 1998 A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity; Nat. Genet. 20 284–287
Doney A, Fischer B, Frew D, Cumming A, Flavell D M, World M, Montgomery H E, Boyle D et al. 2002 Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight; BMC Genet. 3 21–28
Doney A S, Fischer B, Cecil J E, Boylan K, McGuigan F E, Ralston S H, Morris A D and Palmer C N 2004 Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes; Diabetologia 47 555–558
Dongxia L, Qi H, Lisong L and Jincheng G 2008 Association of peroxisome proliferator-activated receptor gamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome; Circ. J. 72 551–557
Ek J, Urhammer S A, Sorensen T I, Andersen T, Auwerx J and Pedersen O 1999 Homozygosity of the Pro12Ala variant of the peroxisome proliferation activated receptor-gamma2 (PPARgamma2): divergent modulating effects on body mass index in obese and lean Caucasian men; Diabetologia 42 892–895
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III); JAMA 285 2486–2497
Frederiksen L, Brodbaek K, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S and Urhammer S A 2002 Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome; J. Clin. Endocrinol. Metab. 87 3989–3992
Ghosh S, Singh A K, Aruna B, Mukhopadhyay S and Ehtesham N Z 2003 The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications; Gene 305 27–34
Hivert M F, Sullivan L M, Fox C S, Nathan D M, D’Agostino R B Sr, Wilson P W and Meigs J B 2008 Association of adiponectin, resistin and TNF{alpha} with insulin resistance; J. Clin. Endocrinol. Metab. 93 3165–3172
Kliewer S A, Lenhard J M, Willson T M, Patel I, Morris D C and Lehmann J M 1995 A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation; Cell 83 813–819
Meirhaeghe A, Cottel D, Amouyel P and Dallongeville J 2005 Association between peroxisome proliferator-activated receptor gamma haplotypes and the metabolic syndrome in French men and women; Diabetes 54 3043–3048
Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J et al. 1998 A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans; Hum. Mol. Genet. 7 435–440
Misra A and Vikram N K 2004 Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications; Nutrition 20 482–491
Montagnana M, Fava C, Nilsson P M, Engström G, Hedblad B, Lippi G, Minuz P, Berglund G et al. 2008 The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals; Diabet. Med. 25 902–908
Mori Y, Kim-Motoyama H, Katakura T, Yasuda K, Kadowaki H, Beamer B A, Shuldiner A R, Akanuma Y et al. 1998 Effect of the Pro12Ala variant of the human peroxisome proliferators-activated receptor gamma 2 gene on adiposity, fat distribution, and insulin sensitivity in Japanese men; Biochem. Biophys. Res. Commun. 251 195–198
Nagaev I and Smith U 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle; Biochem. Biophys. Res. Commun. 285 561–564
Oh E Y, Min K M, Chung J H, Min Y K, Lee M S, Kim K W and Lee M K 2000 Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects; J. Clin. Endocrinol. Metab. 85 1801–1804
Patel L, Buckels A C, Kinghorn I J, Murdock P R, Holbrook J D, Plumpton C, Macphee C H and Smith S A 2003 Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators; Biochem. Biophys. Res. Commun. 300 472–476
Radha V, Vimaleswaran K S, Babu H N, Abate N, Chandalia M, Satija P, Grundy S M, Ghosh S et al. 2006 Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity; Diabetes Care 29 1046–1051
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das A K, Rao P V and Yajnik C S and Diabetes Epidemiology Study Group in India (DESI) 2001 High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey; Diabetologia 44 1094–1101
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S and Vijay V 2003 Metabolic syndrome in urban Asian Indian adults — a population study using modified ATP III criteria; Diabetes Res. Clin. Pract. 60 199–204
Rhee E J, Oh K W, Lee W Y, Kim S Y, Oh E S, Baek K H, Kang M I and Kim S W 2006 Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome; Arch. Med. Res. 37 86–94
Ristow M, Müller-Wieland D, Pfeiffer A, Krone W and Kahn C R 1998 Obesity associated with a mutation in a genetic regulator of adipocyte differentiation; N. Engl. J. Med. 339 953–959
Scacchi R, Pinto A, Rickards O, Pacella A, De Stefano G F, Cannella C and Corbo R M 2007 An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits; Nutr. Metab. Cardiovasc. Dis. 17 632–641
Sicree R, Shaw J and Zimmet P 2006 Diabetes and impaired glucose tolerance; in Diabetes atlas 3rd edition (ed.) D Gan (Belgium: International Diabetes Federation) pp 15–103
Silswal N, Singh A K, Aruna B, Mukhopadhyay S, Ghosh S and Ehtesham N Z 2005 Human resistin stimulates the proinflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway; Biochem. Biophys. Res. Commun. 334 1092–1101
Snehalatha C, Viswanathan V and Ramachandran A 2003 Cutoff values for normal anthropometric variables in Asian Indian adults; Diabetes Care 26 1380–1384
Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S et al. 2001 The hormone resistin links obesity to diabetes; Nature (London) 409 307–312
Stumvoll M and Haring H 2002 The peroxisome proliferators-activated receptor-gamma2 Pro12Ala polymorphism; Diabetes 51 2341–2347
Tai E S, Corella D, Deurenberg-Yap M, Adiconis X, Chew S K, Tan C E and Ordovas J M 2004 Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population; J. Lipid Res. 45 674–685
Tontonoz P, Hu E, Devine J, Beale E G and Spiegelman B M 1995 PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene; Mol. Cell. Biol. 15 351–357
Valve R, Sivenius K, Miettinen R, Pihlajamaki J, Rissanen A, Deeb S S, Auwerx J, Uusitupa M et al. 1999 Two polymorphisms in the peroxisome proliferator activated receptor-gamma gene are associated with severe overweight among obese women; J. Clin. Endocrinol. Metab. 84 3708–3712
Vimaleswaran K S, Radha V, Deepa R and Mohan V 2007 Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians; Metab. Syndr. Relat. Disord. 5 153–162
Wang C, Zhai F, Chi Y and Wang G 2004 Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population; Wei Sheng Yan Jiu. 33 317–320
Way J M, Görggün C Z, Tong Q, Uysal K T, Brown K K, Harrington W W, Oliver W R Jr, Willson T M et al. 2001 Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists; J. Biol. Chem. 276 25651–25653
Zimmet P, Magliano D, Matsuzawa Y, Alberti G and Shaw J 2005 The metabolic syndrome: a global public health problem and a new definition; J. Atheroscler. Thromb. 12 295–300
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haseeb, A., Iliyas, M., Chakrabarti, S. et al. Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor γ and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population. J Biosci 34, 405–414 (2009). https://doi.org/10.1007/s12038-009-0047-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12038-009-0047-x